Treatment Patterns and Clinical Outcomes among Advanced NSCLC Patients with EGFR exon 20 Insertion Mutations in China

被引：0
|
作者：
Wang, Y. [1 ]
Lin, H. M. [2 ]
Ning, N. [3 ]
Du, F. [4 ]
Gao, X. [3 ]
Dong, Q. [2 ]
Yang, G. [1 ]
Xu, H. [5 ]
He, Y. [6 ]
Zhou, C. [6 ]
机构：
[1] Natl Clin Res Ctr Canc, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing, Peoples R China
[2] Takeda Dev Ctr Amer Inc, Lexington, MA USA
[3] OPEN Hlth, Bernardsville, NJ USA
[4] OPEN Hlth, Shanghai, Peoples R China
[5] Chinese Acad Med Sci & Peking Uni, Canc Hosp, Natl Clin Res Ctr Canc, Dept Comprehens Oncol,Natl Canc Ctr, Beijing, Peoples R China
[6] Shanghai Pulm Hosp, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Non-small cell lung cancer in China; Treatment patterns; Clinical outcomes;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP10.01-17
引用
收藏
页码：S609 / S609
页数：1
相关论文
共 50 条
  • [31] Real-World Characteristics and Outcomes of Advanced NSCLC Patients with Exon 19 or 21 EGFR Mutations
    Winfree, K.
    Molife, C.
    Peterson, P.
    Chen, Y.
    Visseren, C.
    Beyrer, J.
    Leusch, M.
    Dimou, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S23 - S23
  • [32] Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC
    Angela Zupa
    Giulia Vita
    Matteo Landriscina
    Luciana Possidente
    Michele Aieta
    Alfredo Tartarone
    Giuseppina Improta
    Medical Oncology, 2012, 29 : 3198 - 3201
  • [33] Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC
    Zupa, Angela
    Vita, Giulia
    Landriscina, Matteo
    Possidente, Luciana
    Aieta, Michele
    Tartarone, Alfredo
    Improta, Giuseppina
    MEDICAL ONCOLOGY, 2012, 29 (05) : 3198 - 3201
  • [34] Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLC
    Ou, Sai-Hong Ignatius
    Hong, Jin-Liern
    Christopoulos, Petros
    Lin, Huamao M.
    Vincent, Sylvie
    Churchill, Eric N.
    Soeda, Junpei
    Kazdal, Daniel
    Stenzinger, Albrecht
    Thomas, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (06) : 744 - 754
  • [35] Clinicopathological Characteristics for NSCLC Harboring EGFR Exon 20 Insertion
    Morikawa, K.
    Kakinuma, K.
    Inoue, T.
    Mineshita, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S496 - S496
  • [36] Preliminary clinical investigations and mechanism exploration of furmonertinib in NSCLC with EGFR exon 20 insertion
    Zhang, X.
    Feng, G.
    Han, H.
    Dong, B.
    Yang, Y.
    Zhu, H.
    Fan, S.
    Tang, H.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S63 - S63
  • [37] Molecular characteristics of EGFR exon20 mutations in NSCLC patients.
    Ji, Yinghua
    Wang, Jin
    Meng, Xiangli
    Xie, Jinling
    Lu, Ping
    Li, Mengmeng
    Luo, Ningning
    Qi, Yingxue
    Zhu, Xiaofeng
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Clinicopathological Characteristics of 11 NSCLC Patients with EGFR-Exon 20 Mutations
    Lund-Iversen, Marius
    Kleinberg, Lilach
    Fjellbirkeland, Lars
    Helland, Aslaug
    Brustugun, Odd Terje
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : 1471 - 1473
  • [39] A study of the efficacy and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in NSCLC
    Choi, D.
    Jung, H. A.
    Park, S.
    Sun, J-M.
    Ahn, J. S.
    Ahn, M-J.
    Lee, S-H.
    ANNALS OF ONCOLOGY, 2023, 34 : S1696 - S1696
  • [40] Educational Impact of A Clinical Advances Curriculum On EGFR Exon 20 Insertion Mutated NSCLC And EGFR TKI-Resistant NSCLC
    Dorkhom, N. V.
    Cannon, M.
    Cohen, J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S645 - S645
12345